Chronische Pijnrevalidatie

Initiatief: VRA Aantal modules: 14

Interdisciplinaire revalidatie versus monodisciplinaire revalidatie

Uitgangsvraag

Uitgangsvraag Comparison 2

What is the effectiveness of interdisciplinary rehabilitation compared to monodisciplinary rehabilitation in adult patients with musculoskeletal chronic pain?

Aanbeveling

Overwegingen

Onderbouwing

HRQoL

Very low
GRADE

The evidence is very uncertain about the effect of interdisciplinary rehabilitation on HRQoL when compared with monodisciplinary rehabilitation in adults with musculoskeletal chronic pain.

 

Sources: Ronzi (2017); Tavafian (2011, 2014, 2017); Van Eijk-Hustings (2013); Becker (2000);

 

Disability

Very low
GRADE

The evidence is very uncertain about the effect of interdisciplinary rehabilitation on disability when compared with monodisciplinary rehabilitation in adults with musculoskeletal chronic pain.

 

Sources: Bendix (2000); Jousset (2004); Kääpä (2006); Roche (2007, 2011); Ronzi (2017); Tavafian (2011, 2014, 2017); Castel (2013); Van Eijk-Hustings (2013); Martín (2012, 2014a, 2014b);

 

Self-efficacy

No
GRADE

 

Sources: -

 

Pain

Very low
GRADE

The evidence is very uncertain about the effect of interdisciplinary rehabilitation on pain when compared with monodisciplinary rehabilitation in adults with musculoskeletal chronic pain.

 

Sources: Bendix (2000); Jousset (2004); Kääpä (2006); Roche (2007, 2011); Ronzi (2017); Castel (2013); Becker (2000); Turner-Stokes (2003);

 

Anxiety

Very low
GRADE

The evidence is very uncertain about the effect of interdisciplinary rehabilitation on anxiety when compared with monodisciplinary rehabilitation in adults with musculoskeletal chronic pain.

 

Sources: Jousset (2004); Roche (2007, 2011); Ronzi (2017); Castel (2013); Martín (2012, 2014a, 2014b); Becker (2000);

 

Depression

Very low
GRADE

The evidence is very uncertain about the effect of interdisciplinary rehabilitation on depression when compared with monodisciplinary rehabilitation in adults with musculoskeletal chronic pain.

 

Sources: Jousset (2004); Kääpä (2006); Roche (2007, 2011); Ronzi (2017); Castel (2013); Martín (2012, 2014a, 2014b); Becker (2000);

 

Cost-effectiveness

No
GRADE

 

Sources: -

 

Work participation

Low
GRADE

Interdisciplinary rehabilitation may result in little to no difference in work participation when compared with monodisciplinary rehabilitation in adults with musculoskeletal chronic pain.

 

Sources: Bendix (2000); Jousset (2004); Roche (2007, 2011); Ronzi (2017); Skouen (2006)

Comparison 2. Interdisciplinary rehabilitation compared to monodisciplinary care

 

Bendix (2000) performed a randomized controlled trial, including 138 patients with chronic back pain. The intervention program (n=64, mean age: 40, 33% men) focused on self-responsibility and activity with a multidisciplinary approach and lasted for 3 weeks (9h/d). Daily components included 1) physical training under supervision of a physical therapist; 2) occupational therapy under supervision of an occupational therapist; 3) group therapy sessions led by a psychologist; 4) stretching supervised by a physical therapist; 5) theory on anatomy, physiology and pathology taught by a physician, physical therapist, occupational therapist or social worker; and 6) recreational activities under supervision of the physical therapist and/or occupational therapist. The control program (n=74, mean age 41, 35% men) consisted of intensive physical training and was identical to the physical training program of the intervention group. Outcome measures were self-efficacy/disability (in terms of ADL assessment), pain intensity and work participation (in terms of sick leave days). The follow-up measures were taken at 12 months.

 

Jousset (2004) performed a randomized controlled trial, including 86 patients with low back pain. Patients were allocated to either the functional restoration program (n=43, mean age 41.4±7, 70% men) or the active individual therapy program (AIT) (n=41, mean age 39.4±5.9, 63% men). The functional restoration program consisted of physical training, occupational therapy, and psychological support and lasted five weeks. AIT consisted of a five-weeks therapy (3 d/w, 1h/d) (+ 2x p/w 50 min.) and consisted of flexibility training, pain coping strategies, strengthening exercise, functional training and advice to perform regular sports activities supervised by physiotherapists. Outcome measures included HR-QoL and disability (Quebec Disability Scale), pain intensity, anxiety and depression (HAD scale) and work participation (in terms of ‘number of sick leave days’). Follow-up measurements were taken at six months.

 

Kääpä (2006) conducted a randomized controlled trial including 120 patients with low back pain. Patients were randomized into a multidisciplinary group rehabilitation (n=59; mean age 46±7.9; no men) or the individual physiotherapy (n=61; mean age 46.5±7; no men). The multidisciplinary group rehabilitation program was an eight-week program and took place in small groups of six to eight patients. The program consisted of cognitive behavioral stress management, applied relaxation sessions, back school education including occupational intervention and a physical exercise program, involving physiotherapists, occupational physiotherapists, psychologist and a physician. The individual psychotherapy lasted six to eight weeks (10x1h sessions) and focussed on passive pain treatment, light active exercise, recommendation of general physical training and light home-exercise program. Outcome measures were Oswestry disability index, pain intensity, depression and work participation in terms of ‘number of sick leave days’. Measurements were taken after the intervention period, at 6months, 12months and 24months.

 

Roche (2007, 2011) performed a randomized controlled study including 132 patients with chronic low back pain. Patients were randomized into two groups and allocated to the active individual therapy program (AIT, n=64, mean age: 38.7±6.1, 63% mean) or the functional restoration program (FRP, n=68, mean age: 40.8±7.4, 68% men). AIT included individual rehabilitation with a physiotherapist including individual home-exercises. The functional restoration program involved group exercises supervised by a physiotherapist. Patients weekly visited a medical specialist who was the medical supervisor of the program, and patients were referred to the psychologist in the first week and for further treatment if requested. At the start and end of the treatment (after 5 weeks), all patients were assessed by physiatrists. The physical evaluations were performed by physiotherapists. Measurements were taken at end of treatment and one year after the intervention. Outcome measures included pain intensity (VAS) and work participation (in term of return to work).

 

Ronzi (2017) performed a randomized controlled trial in France comparing three treatment strategies for chronic low back pain. The three treatment strategies involved: (1) intensive and multidisciplinary program conducted in a rehabilitation centre; (2) less intensive outpatient program conducted by a trained private physiotherapist; and (3) mixed strategy combining the same outpatient program associated with a weekly multidisciplinary intervention. Treatment arms 1 and 2 are relevant for the current clinical question. A total of 159 patients were randomly allocated to the three treatment arms, 105 of them were allocated to the two relevant treatment arms. This involved a Functional Restoration Program (FRP) (intervention group: 49 patients, 55% male, median age 40 (IQR 33 to 48) and an Ambulatory Individual Physiotherapy (AIP) group (control group: 54 patients, 61% male, median age 42 (IQR 38 to 48). Measurements were performed at inclusion and at 12 months of follow-up. Outcome measures included quality of life (Short Form Health Survey questionnaire (SF-36); 0-100), social ability (Dallas Pain Questionnaire (DPQ); 0-100%), pain (VAS; 0-100mm), and being fit for work, evaluated by the duration of sick leave during one year (the number of days’ sick leave during the preceding 12-months and during the 12-months of the study was collected for each participant),

 

Tavafian (2011, 2014, 2017) performed a randomized controlled study including 197 patients with chronic low back pain. Patients were randomized to either the intervention group receiving a group-based, 5-session multidisciplinary rehabilitation program plus oral medication(n=97, mean age: 44.6±10.2, 27% men) or to the control group receiving just oral medication (n=100, mean age45.9±11.3 17% men). The intervention program involved five, 2-hour sessions given by a physiotherapist, rheumatologist and a psychologist and were followed by monthly booster sessions and monthly telephone counselling to encourage participants to maintain improved behaviors. Outcome measures included HRQoL (SF-36) and disability (Quebec Disability Scale and Ronald-Morris Disability).

 

Castel (2013) performed a randomized controlled study including 155 patients with fibromyalgia in Spain. Patients were randomized to either the intervention group receiving multidisciplinary treatment including CBT and physical therapy delivered by a

clinical psychologist and a physiotherapist specifically trained for this program, respectively. In addition, patient received conventional pharmacologic treatment (n=81, mean age: 49.0 ± 6.8, no men). Patients randomized to the control group only received conventional pharmacologic treatment (n=74, mean age: 48.8 ± 7.2, no men). Outcome measures were pain intensity, anxiety/depression and disability. Measurements were taken after the intervention period, at 3 months, 6 months and 12 months.

 

Van Eijk – Hustings (2013) conducted a randomized controlled trail with fibromyalgia patients from outpatient rheumatology clinics and allocated these patients into one of the three arms: 1) a 12-week multidisciplinary intervention with aftercare (MD, n=108, mean age 41.6±8.8, 6% male); 2) a 12-week group course aerobic exercise which was given twice a week by a trained physiotherapist aerobic exercise (AE, mean age 43.9±7.6, n= 47, no men) or 3) usual care that comprised at least individualised education about fibromyalgia and lifestyle advice by a rheumatologist or a specialised rheumatology nurse within one or two consultations, but could also include a diversity of other treatments such as physiotherapy or social support from the rheumatology nurse (n=48, mean age: 42.9±11.0, 2% men). Outcome measures included HR-QoL measured by EQ5D and the Fibromyalgia Impact Questionnaire-total (FIQ-total). The Fibromyalgia Impact Questionnaire (FIQ) is a ten-item multidimensional instrument on function in the past week. Follow-up questionnaires were sent to all patients immediately following the 12-week program and 18 months afterwards. The results of the treatment arms were only tested statistically between the multidisciplinary group and the usual care group.

 

Martín (2012, 2014a, 2014b) performed a randomized controlled study including 110 patients with fibromyalgia. Patients were randomized into two groups and allocated to a PSYMEPHY group (n=54, mean age: 48.7±8.6, 9% men) or the control group (n=56, mean age: 51.6±9.7, 9% men). The control group received standard pharmacologic therapy. The PSYMEPHY group received in addition to the standard pharmacologic therapy, an interdisciplinary treatment (12 sessions for 6 weeks) which consisted of coordinated psychological, medical, educational, and physiotherapeutic interventions. The follow-up period was 6 months for the control group and 12 months for the PSYMEPHY group (the patients in the control group were invited to participate in the PSYMEPHY treatment after 6 months). Comparisons were made between PSYMEPHY and control groups at the 6-month follow-up, not at 12-month follow-up. Outcome measures included total Fibromyalgia Impact Questionnaire-score and anxiety and depression (HADS).

 

Skouen (2006) randomized patients with chronic widespread pain into light multidisciplinary treatment, extensive multidisciplinary treatment and treatment as usual. Because approximately 50% of the light treatment group received exercise therapy from external physiotherapists, this treatment arm was not included in our analyses because this was not in agreement with the criteria for interdisciplinary treatment from Gatchel et al. Patients in the extensive multidisciplinary treatment program (n=42, mean age 42.6 ± 11.0, 39% men) received a treatment program which lasted for 4 weeks, with 6 h of sessions 5 days per week. The program included group sessions, education, exercise training and occasional workplace intervention. The group sessions discussed cognitive coping strategies and gave advice (2 hours per week). Anti-depressant medication was used if necessary. Patients were encouraged to use analgesics as little as possible. Education sessions involved anatomy, pain mechanism, exercise training and applying mental coping strategies at work and daily life (2 hours per week). The extensive program also focused on avoiding fear. The patients received an individually tailored graded exercise training program based on physical tests. The patients exercised daily under continuous supervision by physiotherapists to the patients for 1.5–3.5 hours per day. The patients in the treatment-as-usual group (n=85, mean age 43.1±10.7, 43%) were referred to their general practitioner. In 2006 in Norway,

some general practitioners give CWP patients pain medication, anti-depressant medication and refer them to physiotherapists or chiropractors. Other general practitioners have started to change their way of handling these patients. More patients receive a cognitive

 treatment approach and traditional physiotherapy is changed to body awareness treatment. The study reported on return to work up to 54 months after treatment.

 

Becker (2000) performed a randomized controlled trial in Denmark, including patients with chronic non-malignant pain. Pain was localized from highest to lowest prevalence: extremity, low back, abdominal (±20%), more than three locations, thoracic, rectal (2%), head or facial (1%). Patients were randomly allocated to three treatment arms: multidisciplinary pain centre treatment ([MPT-group] n=56, mean age 57.7±15.8, 39% men); treatment by a general practitioner after initial supervision by a pain specialist ([GP-group] n=58, mean age 55.1±14.6, 31% men) and a waiting list. The current analysis does not include waiting list, as this was not part of our pre-defined PICOs. The MPT-group received outpatient treatment at the ‘multidisciplinary pain centre’. The treatment program was carried out on an individual basis and the staff consisted of anaesthesiologists, psychologists, physiotherapists, nurses and a social worker. In the GP-group the intervention consisted of a single initial consultation during which the GP and a pain specialist evaluated the patient together and established a treatment plan. Treatment consisted primarily of analgesic tailoring, however, during the consultation the importance of education on the physiology and psychology of pain and behavioural pain management strategies were also emphasized. Outcome measures included pain intensity as measured by the VAS, Hospital Anxiety and Depression Scale (scores on each subscale range from 0 – 21, scores above 8 indicate that a depressive or anxiety disorder is likely to be present) and HR-QoL as measured by the SF-36.

 

Turner-Stokes (2003) included 126 patients with chronic pain in a randomized controlled trial. Included patients experienced pain that could affect any part of the body. However, the majority (95%) had pain centered on the spine. Patients were randomized into a group-based multidisciplinary program (n=73; mean age 47.32±10.17; 26% men) or individual therapy program (n=53; mean age 48.32±12.26; 38% men). Both programs had a duration of eight weeks. The group-based multidisciplinary program was done in small groups of six to eight people and consisted of relaxation training, cognitive coping strategies, exercise encouragement and pacing of daily activities, under supervision of staff from psychology, physiotherapy, occupational therapy and medical staff. The individual program consisted of a one-hour sessions with a psychologist, every other week. Based on assessment by a physiotherapist, the psychologist gave tailored advice regarding physical activity and exercise, throughout the program. Measures were taken at 2mo and 12mo. Outcome measures were HRQOL (WHYMPI), pain (WHYMPI), anxiety (STAI) and depression (BDI).

 

Table 2.1 Additional study and baseline characteristics and outcomes of included studies – interdisciplinary rehabilitation vs monodisciplinary care

Study

Study population

Intervention and Control

Outcomes

Remarks

Bendix (2000)

138 patients with chronic low back pain

 

Inclusion criteria:

-be in a precarious work situation

 

Exclusion criteria:

-herniated nucleus pulposus

-surgically treatable instability

-inflammatory back disease

-osteoporosis

-cancer

-medical or psychiatric condition preventing intensive physical training

-already received a disability pension

 

Intervention (n=64):

The functional restoration program focussed on self-responsibility and activity with a multidisciplinary approach. The program lasted for 3 weeks, 9h/d.

 

The daily schedule included:

-physical training under supervision of a physical therapist (2h)

-occupational therapy under supervision of an occupational therapist (1.5h)

-group therapy sessions led by a psychologist (1.5h)

-stretching supervised by a physical therapist (0.5h)

-theory on anatomy, physiology and pathology taught by a physician, physical therapist, occupational therapist or social worker. (1h)

-recreational activities under supervision of the physical therapist and/or occupational therapist (1h)

 

Control (n=74):

Patients in the outpatient intensive physical training program received the same physical training as patients in the intervention group. The control program lasted for 8 weeks, three times per week, 1,5 h/session.

 

Self-efficacy/disability (ADL assessment; median [0-30])
Base:
I:16 (12–20) / C: 16 (12–21)
12mo:

I: 12 (IQR=6-21) / C: 13 (IQR=9-19)
p-value= 0.41

 

Back Pain intensity (median, (IQR) [0-10])
Base: I: 5.1 (4–7) / C: 6.0 (5–7)
12mo: I: 5.1 (2-7) / C: 5.7 (3-7.3)

 

Work participation (days sick leave; median)
Base: -

12mo: I: 5.5 (0-113) / C: 2.5 (0-301)

P-value = 1.00

 

Loss to follow-up:

1 year I: 17.2% / C: 31.1%

 

 

 

 

Jousset (2004)

86 French patients with low back pain

 

Inclusion criteria:

- LBP patients, age 18-50 years

- Engaged in a nonlimited work contract

- risk of inability to work by LBP

- Threatened in their job situation by CLBP

- Not relieved by conventional medical or surgical interventions

 

Excluding criteria:

- LBP of specific origin (< 4 months)

- Recent spinal surgery

- Cardiac or respiratory abnormalities after exercise stress test

- Precluding psychiatric disorders

- Receiving of disability pensions

 

Intervention (n=44):

Functional Restoration Program ( FRP) for 5 weeks

5 days per week

6 hours per day

 

Aspects:

 

Intensive physical training

-warm-up, stretching, proprioception

-strengthening exercises (physiotherapist -supervised)

-aerobic activities

-endurance training

-balneotherapy

 

Occupational therapy providing work simulation

 

-individual interventions such as consultations with the physiatrist, psychologist and dietician

 

Control (n=42):

Active individual therapy (AIT)

5 weeks

3x per week (+ 2x p/w 50 min.)

1 hour per day

 

Aspects:

Active exercises

Starting with 2 weeks with focus on flexibility, range of motion, pain coping strategies, followed by strengthening exercise and functional training and advice to perform regular sports activities

Disability (ADL-Dallas questionnaire component ADL [0-100])
Base: I: 53.7 (16.7) / C: 50.3 (16.7)

6mo I: 36.7 (23) / C: 41.5 (24.4)

Between-group difference p=0.36

 

Disability (Quebec Disability Scale[0-100])

Base: I: 34.6 (15.4) / C: 31.6 (15.9)
6mo I: 22.0 (16) / C 22.9 (17.7)

Between-group difference: p=0.80

 

Pain intensity (during the past 48 hours was evaluated on a 10-cm horizontal visual analogical scale [0-10])
Base: I: 5.0 (2.2) / C: 4.6 (2.2)

6 mo I: 3.1 (2.5) / C: 4 (2.8)

Between-group difference: p=0.16

 

Anxiety/depression (HAD scale [0-21])
Base: I: 17.0 (6.5) / C: 14.3 (6.1)

6mo I: 12.7 (7.2) / C: 13.4 (6.4)

Between-group difference: p=0.72

 

Work participation (number of sick-leave days)
Base: -

6mo I: 28.7 (44.6) / C: 48.3 (66.0)

Between-group difference: p=0.12

 

Overall loss to follow-up: 1%

 

Kääpä (2006)

120 women (Finland) with low back pain

 

Inclusion criteria:

- age 22-57 yo

 

Excluding criteria:

-Clinical symptoms suggesting an acute disc prolapse accompanied by nerve root entrapment.

-recent back surgery

-severe cardiovascular or other disorder interfering with active rehabilitation

-specific back disorder

-severe mental illness

-more than 90 days off work because of LBP during preceding year.

-pension within 2 years

-pregnancy

-ongoing/planned LBP rehabilitation

 

 

 

 

 

Intervention (n=59)

Multidisciplinary rehabilitation program(MR) for 8 weeks (total of 70h),

 

Aspects:

-cognitive-behavioral stress management

-applied relaxation sessions

- back school education including occupational Intervention

-physical exercise program.

- in small supervised groups (6-8)

 

Control (n=61)

Individual physiotherapy (IP) for 6-8 weeks consisting of 10x1h sessions

 

Aspects:

-passive pain treatment

-light active exercise

- recommendation of general physical training

-light home-exercise program

 

Disability (Oswestry disability index)

Base I: 25.4 (10.6) / C: 23.8 (11.7)

After re I: 20.9 (10.1) / C: 21.6 (11.4)

6 mo I: 20.4 (11.6) / C: 18.0 (11.5)

12 mo I: 18.9 (12.8) / C: 18.5 (12.4)

24 mo I: 19.7 (14.3) / C: 19.3 (13.1)

Not statistically significant

 

Low back pain intensity [0-10]

Base: I: 4.6 (1.9) / C: 5.0 (2.6)

After re I: 3.3 (2.5) / C: 3.4 (2.4)

6 mo  I: 3.3 (2.5) / C 3.4 (2.5)

12 mo I: 3.6 (2.7) / C: 3.4 (2.5)

24 mo I: 3.5 (2.6)/ C: 4.0 (2.9)
Not statistically significant

 

Depression (DEPS [0-30])

Base I: 7.5 (5.2) / C: 6.7 (5.5)

After re I: 5.5 (5.5) / C: 5.7 (5.2)

6 mo I: 5.7 (4.6) / C: 5.8 (5.7)

12 mo I: 6.6 (5.8) / C: 5.0 (4.0)

24 mo I 6.7 (5.3) / C: 5.7 (4.7)
Not statistically significant

 

Work participation (number of sick leave days during last year)
Base: o

after 1y. (p=0.65)

0 days I: 61.5%/ C: 56.4%

1-30 days I: 32.7% / C: 34.6%

>30 days I: 5.8% / C: 9.0%

Loss to follow-up

6mo I: 2% / C: 7%

12mo I: 10% / C: 11%

24mo I: 17% / C: 25%

All participants were women

 

At inclusion, participants had only mild to moderate symptoms à this could (partially) explain the absence of differences between the groups

 

Sick leaves probably not reliable outcome since the temporary workers were afraid to go on sick leave during working hours

 

The intervention contrast between the IP and MR groups was, however, somewhat decreased by the instructions of exercise

treatment

 

Some subjects, particularly those doing

physically hard work, perceived participation during working

hours in MR program as burdensome

Roche (2007, 2011)

132 French patients with chronic low back pain

 

Inclusion criteria:

- Aged 18-50 years,

- Diagnosed with LBP for ≥3mo,

- Patients on sick leave or at risk of work disability.

 

Exclusion criteria:

- Patients with malignant,

traumatic, infectious, or inflammatory LBP,

- Patients with acute LBP, spondylolisthesis, or cardiac/ respiratory insufficiency,

- Patients with articular or neurologic impairment,

- Patients with psychiatric disorders,

- Patients receiving disability pensions or refusing to participate in the study.

Intervention (n=68): functional restoration program (FRP). For 5wks, 6h a day, 5d/week in groups of 6-8 patients. Exercises were supervised by a physiotherapist. Each week patients attended a clinic with the specialist in physical medicine and rehabilitation who was the medical supervisor of the program. They were referred to a psychologist at least once in the first week and for further treatment if requested.

 

Control (n=64): individual therapy program (AIT). For 5wks and included individual rehabilitation with a private physiotherapist for 1h 3x/week and individual exercises to be performed at home for 50min 2x/week. Exercises were supervised directly by a physiotherapist.

 

Both groups (n=132):

- Patients were off work during 5wks,

- At T0 and T5, patients were assessed in a rehabilitation centre by physiatrists.

- Physical evaluations were performed by physiotherapists.

Measurements: 5wk, 12mo

 

Disability (Daily activities - subscale Dallas Pain Questionnaire, [all subscales 0-100%])
Base: FRP: 51.9% / AIT: 51.0%

T0-5 weeks: FRP: -21.5% / AIT: -17.2%

T0-12 mo: FRP: -20.3% / AIT: -10.4%
Not statistically significant

 

Disability (Work and leisure – subscale Dallas Pain Questionnaire, [all subscales 0-100%])

Base: FRP: 51.9% / AIT: 58%

T0-5 wks: FRP: -22.0% / AIT: -19.8%

T0-12 mo: FRP: -22.8% / AIT: -17.7%
Not statistically significant

Disability (Social interaction – subscale Dallas Pain Questionnaire, [all subscales 0-100%])

Base: FRP: 30.7% / AIT: 27.4%
T0-5 weeks:
FRP: -13.6% / AIT: -4.1%

T0-12 mo FRP: -15.7% / AIT: -1.4%
Statistically significant

 

Pain (VAS [0-10])

Base: FRP: 4.7 (2.1) / AIP: 4.5 (2.1)

T0-5wk FRP: -1.9 / AIP: -1.5

T0-12mo: FRP: -1.7 / AIP: -1.0
Not statistically significant


Anxiety and depression (subscale Dallas Pain Questionnaire, [all subscales 0-100%])
Base: FRP: 36.9% / AIP: 30.8%

T0-5wk: FRP: -17.6% / AIT: -7.4%

T-0-12 mo: FRP: -15.6% / AIT: -4.8%
Statistically significant

 

Return to work (%)
Base: -

T0-5 weeks: FRP: 86.8% / AIT: 85.7%

p-value>0.05

- Compliance with both programs was not assessed.

 

- The main limitation of this study is the lost to follow-up rate. At 5wks some patients did not complete all measurements (available FRP: all data n=63, endurance n=63, return to work n=67, DPQ n=67. Available AIT: all data n=56, endurance n=56, return to work n=6, DPQ n=63). After 1 year, 19 (14.4%) patients were missing and they were more frequently included in AIT than in FRP (AIT: 15/64 patients, FRP: 4/68 patients, p=0.006).

 

- Intention-to-treat analysis could not be performed (Roche 2011).

 

Ronzi (2017)

105 French patients with chronic low back pain

 

Inclusion criteria:

Participants were subjects of working age suffering from non-specific chronic LBP according to the usually accepted scientific criteria.

Patients could be included if they were aged 18 to 55, were able to sign the informed consent form, suffered from a non-specific LBP for at least three

months without improvement which had led to at least one month’s sick leave during the preceding year and/or three months’ sick leave during the preceding two years, and were on an open-ended

or a fixed-term contract of work in the public or private sector.

 

Exclusion criteria:

No possibility to follow one of three programs of study

Pregnant women, new mothers or mothers who are breastfeeding.

No affiliation to the French social system.

 

Intervention group: Functional Restoration Program (FRP) (n=49): The group performed exercises supervised by a physiotherapist who adjusted the exercise intensity

to each participant every week. The endurance training was adapted to each participant’s heart rate and to the exercise stress test performed before the program. This program involved six hours of treatment a day, five days a week in group of six to eight patients.

 

Control group: Ambulatory Individual Physiotherapy (AIP) (n=54)

Ambulatory Individual Physiotherapy (AIP) included individual rehabilitation with a private physiotherapist for one hour, three times a week and individual exercises to be performed at home twice a week for 50 minutes. The mixed strategy includes AIP combined with five one-day group sessions.

 

 

Measurements: at inclusion (I: n=49 / C: n=54) and 12-months follow-up (I: n=43 / C: n=31)

 

HRQoL SF-36 PCS (0-100), median (IQR)

Pre: I: 35.7 (29.4 to 39.5)/ C: 35.6 (31.9 to 37.2)

12mo: I: 39.1 (33.8 to 50.4) / C: 37.5 (33.0 to 46.8)

 

HRQoL SF-36 MCS (0-100), median (IQR)

Pre: I: 43.3 (32.1 to 49.8) / C: 41.2 (36.1 to 50.8)

12mo: I: 48.3 (42.1 to 53.4) / C: 48.9 (41.4 to 54.8)

 

Dallas Pain Questionnaire daily activity subscale, % (IQR)

Pre: I: 63 (51-72) / C: 54 (48-69)

12mo: I: 51 (12 to 64.5) / C: 54 (36 to 63)

 

Dallas Pain Questionnaire work and leisure subscale, % (IQR)

Pre: I: 65 (50 to 75) / C: 56 (50 to 75)

12mo: I: 45 (10 to 65) / C: 40 (25 to 65.5)

 

Dallas Pain Questionnaire anxiety/depression subscale, % (IQR)

Pre: I: 45 (20 to 60) / C: 40 (15 to 55)

12mo: I: 30 (5 to 45) / C: 30 (5 to 45)

 

Dallas Pain Questionnaire social interaction subscale, % (IQR)

Pre: I: 30 (20 to 40)/ C: 25 (10-45)

12mo: I: 15 (0 to 42.5) / C: 25 (15 to 50)

 

Intensity of pain on VAS (mm) (0-100), median (IQR)

Pre: I: 54 (45 to 65) / C: 45 (24 to 65)

12mo: I: 45 (25 to 59) / C: 33 (19 to 48)

 

Hospital anxiety and depression scale (HADS) (0-21), median (IQR)

Pre: I: 17 (12 to 21) / C: 16 (12 to 21)

12mo: I: 11.5 (7.5 to 18) / C: 13 (8 to 19)

 

Number of sick-leave days during the

preceding 12 months, median (IQR)

Pre: I: 256 (195 to 325) / C: 219 (126-318)

12mo: I: 50.5 (0 to 200) / C: 45 (0-98)

 

Only the total HADS score is reported, not separately for the subscales anxiety and depression

 

 

 

 

Tavafian (2011, 2014, 2017)

132 Iranian patients with chronic low back pain

 

Inclusion criteria:

- CLBP patients aged ≥18 years.

- Pain for ≥90 days.

- Primary causes of CLBP were herniated intervertebral disc, facet arthropathy, and lumbar arthrosis.

 

Exclusion criteria:

- Back surgery within last 2 years.

- Recent vertebral fracture.

- Vertebral malignancy.

- Infection in the back.

- Spondylolisthesis.

- Spinal stenosis.

- Inability to participate in the multidisciplinary program sessions,

- Current pregnancy.

- Residency outside of Tehran, insufficient address / phone number for follow ups.

- Difficulty understanding Farsi language.

- Unwillingness to enter to the study or comply with the study protocols.

Intervention group (n=97):

5x 2-hour sessions in one week (group), plus monthly booster sessions and telephone counselling. Aspects:

- Education (anatomy, risk factors, lifestyle advice, posture, diagnosis, pain education).

- Exercises (stretching, strength, relaxation exercises).

- Psychologist (coping, stress, perceptions of control, emotional reactions, problem solving, relaxation).

- CBT (maladaptive cognitions, fear avoidance, activity participation,

adjustment to pain).

- Motivational counselling.

- Medication (analgesics, muscle relaxants, NSAIDs, anti-depressants)

 

Control group (n=100):

Usual care, medical management, mostly medication prescription.

 

Both groups were evaluated every 3 months by the same rheumatologist.

Throughout the study, medications were prescribed for patients in the 2 groups as needed.

 

6mo: I: 97 vs C: 100

12mo: I: 87 vs C: 91

24mo: I: 82 vs C: 83

 

 

 

HRQoL (SF-36), two example domains:

SF-36 Physical function
Base:
I: 54.61 (23.27) / C: 54.53 (23.30)

3mo I: 68.64 (23.39) / C: 60.93 (22.04)

6mo I: 77.77 (18.71) / C: 63.69 (21.88)

12mo I: 80.3 (18.6) / C: 64.4 (22.8)

24mo I: 56.2 (22.5) / C: 55.6 (22.8)

 

SF-36: Mental Health
Base: I: 47.43 (13.96) / C: 44.00 (13.10)
3mo: : I: 66. 2 (20.4)/ C: 58.3 (23.1)
6mo:
I: 67.2 (22.1)/C: 60.9 (23.4)

12 mo: I: 71.8 (20.2)/ C: 58.9 (24.9)
24 mo
: I: 48.1 (13.6)/C: 43.8 (12.01)

Time*Group t0-t6: p-value <0.05
7 subscales including physical function, role physical, role emotional, bodily pain, general health, social function, and vitality

Time*Group t3-t12: p-value <0.05 physical function, mental Health

Time*group t3-t24: p-value <0.05 physical function, mental health

 

Disability (Quebec Disability Scale)
Base: I: 35.45 (20.19) / C: 33.08 (19.69)

3mo I: 23.48 (18.54) / C: 32.70 (18.19)

6mo I: 18.65 (16.14) / C: 27.19 (17.85)

12mo I: 17.4 (16.4) / C: 24.4 (18.3)

24mo I: 35.5 (18.9) / C: 33.5 (18.9)
Time*Group t0-t6:p-value <0.01

Time*Group t3-t12: p-value=0.9

Time*group t3-t24: p-value=0.9

 

Disability (Ronald-Morris Disability)
Base: I: 9.80 (5.07) / C: 10.04 (5.28)

3mo I: 9.01 (5.71) / C: 10.56 (5.78)

6mo I: 7.03 (5.49) / C: 8.80 (5.68)

12mo I: 6.01 (5.8) / C: 8.9 (6.6)

24mo I: 9.9 (4.9) / C: 9.8 (5.3)

Time*Group t0-t6:p-value=0.01

Time*Group t3-t12: p-value=0.5

Time*group t3-t24: p-value=0.4

 

Loss to follow-up

Analyzed at 12mo I: 87; C: 91
Analyzed at 24mo I: 82; C: 83

 

- Limited generalizability: majority of studied participants were women.

 

- There is no exact data regarding the types and quantities of prescribed drugs patients consumed during the study period.

 

- Authors did not ask participants what other health service resources, or

whether additional visits were used during the extended follow-up.

 

- One physician who was not fully

masked to the intervention, treated the patients.

Castel (2013)

Inclusion criteria:
- female sex
- a diagnosis of FM based on the diagnostic

criteria of the American College of Rheumatology
- age

between 18 and 60 years
- between 3 and 8 years of

schooling.

 

Exclusion criteria:

severe chronic pain pathology (e.g., sciatica or complex regional pain syndrome), having been diagnosed with inflammatory rheumatic disease, being physically unable to perform the exercises, an open wound, a skin disease,

being under psychiatric and/or psychological treatment

within the past 3 years, significant suicidal ideation, cognitive or sensorial deterioration that impedes an adequate

follow up to the treatment, or a pending legal resolution for disability.

Intervention (n=81):
CBT delivered by trained clinical psychologist

 Physical therapy delivered by a trained physiotherapist.


Control (n=74):
Conventional pharmaceutical treatment, prescribed by physician.

Disability (FIQ total score)
Base: I 64.6 (16.0); C 66.6 (17.4)
Post: I 47.7 (20.2)‡; C 65.9 (16.1)
3mo: I 55.5 (19.3)§; C 64.6 (17.6)
6mo: I 55.8 (20.9)§; C 67.8 (18.4)

12mo: I 58.8 (20.5); C 69.6 (17.2)
Statistical significance: post, 3mo, 6mo

 

Pain intensity (VAS 0-10)
Base: I 6.8 (1.4); C 7.1 (1.6)
Post: I 5.7 (1.9); C 6.9 (1.8)
3mo: 6.4 (1.9); C 6.8 (1.8)
6mo: 6.4 (1.9); C 7.0 (1.9)

12mo: 6.7 (1.6); C 7.1 (1.8)
Statistical significance: post

 

Anxiety/depression (HADS)
Base: I 21.9 (8.0); C 23.2 (8.1)
Post: I 14.3 (9.0)‡; C 21.7 (8.4)
3mo: I 15.2 (9.1)‡; C 20.6 (8.5)
6mo: I 16.2 (9.3)‡; C 21.5 (8.5)

12mo: 17.1 (9.9)†; C 22.8 (9.2)

Statistical significance: post, 3mo, 6mo, 12mo

 

Van Eijk-Hustings (2013)

203 patients with fibromyalgia

Inclusion criteria:
Patient with fibromyalgia (according to the American College of Rheumatology criteria) recruited from outpatient rheumatology clinics
- 18 – 65 years

 

Exclusion criteria:
Only for MD group:
- pregnancy
- involvement in litigation concerning work disability procedures
- use of other non-pharmacological treatments such as psychological or physical treatment, interfering with the intervention
- alcohol or drugs abuse
- use of walking devices.

 

Intervention group (n=108)Multidisciplinary intervention (MD):
Phase 1 consisted of a 12-week course, three half days per week, with two therapy sessions of 1.5 h duration per day. A trained and experienced multidisciplinary team offered a program of sociotherapy, physiotherapy, psychotherapy and creative arts therapy, using not only group interaction as an additional tool but also paying attention to the patient’s specific needs.
Sociotherapy included education and connected the parts of the program.

Physiotherapy was given twice a week. The program was focused on graded activity, based on time-contingent instead of pain-contingent training and aimed to improve physical fitness and functioning and at learning to enjoy exercise.

Psychotherapy was given once a week and consisted of general information about FM and pain mechanisms. Methods of core qualities [19], rational emotive therapy [20–22] and transactional analysis [17, 18] were used in the sessions.

Creative arts therapy was given once a week and focussed on the opportunity to express feelings by visual arts instead of verbal expressions.

Phase 2 was an aftercare program and consisted of five meetings, scheduled over a period of 9 months. The purpose of these meetings was to repeat the key messages about coping in order to preserve the behavioural change achieved in phase 1


Usual care (UC) (n=48)
Received care as usual that comprised at least individualised education about FM and lifestyle advice by a rheumatologist or a specialised rheumatology nurse within one or two consultations, but could also include a diversity of other treatments such as physiotherapy or social support from the rheumatology nurse

Reported results are Estimated marginal means *±standard error.

 

EQ5D (-0.59-1)

Effect size between I and C at 18 mo:

0.12 (−0.22, 0.46)

 

EQ-VAS (0-100)

Effect size between I and C at 18 mo:

0.22 (−0.12, 0.56)

 

Fibromyalgia Impact Questionnaire-total (FIQ)

Effect size between I and C at 18 mo: 0.25 (−0.09, 0.59)

 

* Cohen defined an ES of ≥0.2 as small, ≥0.5 as moderate and ≥0.8 as large. ES calculations were based on the results of the mixed-model analyses and were considered as statistically significant if zero was not included in the CI.

 

 

Martín (2012, 2014a, 2014b)

132 Spanish patients with fibromyalgia.

Inclusion criteria:

- Patients diagnosed with FM.

- Widespread pain for at least 3mo in combination with pain on palpation in 11-18 specified tender point sites.

- Aged >18 years.

- Continuous chronic pain for at least 6mo.

 

Exclusion criteria:

- Decline participation in study.

- Suffering from a severe psychiatric (psychosis or suicide risk) or organic disorder.

- Were involved in employment-related legal proceedings related to their FM.

PSYMEPHY group (n=54):Patients received the same

pharmacologic treatment as the control group. They also participated in 6wk of PSYMEPHY delivered by a team (incl. physician, clinical psychologist, physiotherapist).

Patients were divided into groups (12p) and received biweekly group sessions (a total of 12 sessions). Various sessions e.g.:

- psychologist + educational activities with a physician and psychologist.

- psychologist + physiotherapist.

Various CBT components (cognitive,

physiological, behavioural, educational) were addressed.

 

Control group (n=56): Current care (=pharmacological treatment tricyclic antidepressant, an analgesic, and an opioid central analgesic.

Fibromyalgia Impact Questionnaire (FIQ):total score [0-100]

Base: I: 76.28 (13.57) / C: 76.23 (14.88)

6mo: I: 70.33 (16.48) / C: 76.81 ± 14.18

p-value=0.02

T0-t6mo: ES: 0.45 (95%CI 0.07 to 0.83, p=0.02)

 

HADS: Anxiety
Base: I: 13.83 (3.39) / 13.39 (3.45)

6mo:I: 13.41 ± 4.31 / C: 12.75 ± 4.55
p-value=0.08

ES: -0.07 (95%CI -0.44 to 0.31, p=0.72)

 

HADS: Depression
Base: I: 10.63 (4.51) / C: 10.57 (4.06)

6mo: I: 9.77 ± 4.09 / C: 10.2 ± 4.22
p-value=0.31

ES: 0.17 (95%CI -0.21 to 0.54, p=0.19)

 

ES: effect size (0.20 = small effect; 0.50 = medium effect); positive ES favors the EG; negative ES favors the CG

- Only PSYMEPHY group had a follow-up period of 12mo. Comparisons were not made between PSYMEPHY and control groups at the 12-month follow-up.

- Limited generalizability:
1) participants were selected from patients referred to a hospital pain management unit (sample might experience greater impact of FM on HRQOL than patients treated in primary care),
2) females were over-represented in our sample.

Skouen (2006)

126 patients with fibromyalgia and chronic widespread pain. Pain was

present on digital palpation in at least 11 of 18 tender

points according to the American College of Rheumatology criteria. Participants had to have a job with no

fixed ending date and be sick-listed more than 50%.

Intervention (n=42)
The extensive multidisciplinary treatment program lasted for 4 weeks, with 6 h of sessions 5 days per week. The program included group sessions, education, exercise training and occasional workplace intervention. The group sessions discussed cognitive coping strategies and gave advice (2 hours per week). Anti-depressant medication was used if necessary. Patients were encouraged to use analgesics as little as

possible. Education sessions involved anatomy, pain mechanism, exercise training and applying mental coping strategies at work and daily life (2 hours per week). The extensive program also focused on avoiding fear. The patients received an individually tailored graded

exercise training program based on physical tests (Ljunggren, 1993). The patients exercised daily under continuous supervision by physiotherapists to the patients for

1.5–3.5 hours per day.

 

Control (n=85)
Treatment as usual group. After the screening and examination by a physician, this group was referred to their general practitioner. In

Norway, some general practitioners give CWP patients pain medication, anti-depressant medication and refer

them to physiotherapists or chiropractors. Other general

practitioners have started to change their way of handling these patients. More patients receive a cognitive

 treatment approach and traditional physiotherapy is changed to body awareness treatment. Data showed that 50% of the patients in the reference group had seen a physiotherapist and 20% had tried alternative treatment of different kinds. This percentage did not differ significantly from the two other groups.

Return to work
In men: Percentage return to work seem similar in the intervention group and in the control group, also not significantly significant.

In women: Until ±24 months, patients in the intervention group returned to work more often. AT 54 months of follow-up, the difference in number of days absent from work between the intervention and control is 206.95 days.

 

Becker (2000)

114 patients with chronic non-malignant pain patients

 

Inclusion criteria:
- age above 18 years

-no psychiatric diseases present

-no illegal use of opioids

-all relevant medical or surgical investigations treatments completed prior to referral

 

Exclusion criteria:
-Patients who were unable to fill in questionnaires were not included

 

Intervention group (n=56):
The MPT-group received outpatient treatment at the Multidisciplinary Pain Centre. The treatment programme was carried out on an individual basis and when considered necessary planned and initiated after a multidisciplinary evaluation. The treatment was of primarily cognitive-behavioural nature and included one or several of the following components: (1) education on the physiology and psychology of pain; (2) teaching of pain management strategies (e.g. relaxation training); (3) analgesic treatment; (4) socio-economic counselling and (5) physiotherapy. The physiotherapy focused primarily on teaching of exercise programs and education in biomechanics. The staff consisted of anaesthesiologists, psychologists, physiotherapists, nurses and a social worker. Throughout the treatment period all patients were seen regularly by the pain specialists. Between consultations patients received telephone counselling from nurses at the pain centre.

 

Control group (n=58):

In the GP-group the intervention consisted of a single initial consultation during which the pain specialist evaluated the patient together with the GP in his/her consultation room. The pain specialist made a medical record and a pain analysis. Based on this the pain specialist and the GP established a treatment plan. Treatment consisted primarily of analgesic tailoring, however, during the consultation the importance of education on the physiology and psychology of pain and behavioural pain management strategies were also emphasized. The protocol allowed patients access to additional monospeciality treatment if needed.

 

HRQoL (SF-36)

For different SF-domains; only social functioning at 6 months showed a clinically relevant difference between intervention and control. This was however not significantly different (p-value>0.05).

 

Pain intensity (VAS)
Base: I: 67 (15) / 65 (23)
3 mo: I: 52 (24)/ C: 63 (20)
6 mo: 52 (24)/ C: 65 (25)
p-value 6 mo: <0.05

 

HADS-anxiety
Base: I 7.8 (4.0) / C: 7.8 (4.2)
3 mo: I: 7.2 (4.2)/ C: 7.5 (4.3)
6 mo: I: 7.1 (4.5))/ C: 8.2 (4.0)
p-value 6 mo: >0.05

 

HADS-depression
Base: I: 6.8 (4.9) / C: 6.4 (4.2)
3 mo: I: 6.3 (5.2)/ C: 6.4 (4.4)

6 mo: I: 6.1 (5.4)/ C: 6.6 (4.3)
p-value 6 mo: >0.05

 

 

 

 

Turner-Stokes (2003)

126 patients with chronic pain

 

Inclusion criteria:

-Age ≥ 18 yo

-Patients experienced pain for > 6mo

-Conventional treatment failed

-No need for hospital transport to clinic

-No major changes in medical management anticipated for next 6 months

 

Exclusion criteria:

-referral for further treatment or investigation

Intervention (n=66):

Group-based multidisciplinary program for 8 weeks

1 afternoon per week

 

aspects:

-relaxation strategies

-cognitive coping strategies

-encouragement for exercise

-pacing of daily activities

With support from psychology, physiotherapy, occupational therapy, medical staff

- in small groups (8-10)

 

control (n=47)

individual program

8 weeks

1h /2wk’s

 

Aspects:

Tailored advice regarding physical activity and exercise delivered by the physiotherapist (via the psychologist)

Measurements: 2mo, 6mo, 12mo

 

Pain severity (WHYMPI, mean diff)

Base: I: 4.26 (1.02) / C: 4.0 (1.14)

2mo -0.07 (95%CI -0.50 to 0.35, p=0.73)

12mo -0.17 (95%CI -0.59 to 0.24, p=0.41)

 

Anxiety (STAI, mean diff)

Base: not reported
 2mo -2.3 (95%CI -6.21 to 1.59, p=0.24)

12mo -3.43 (95%CI -7.81 to 0.94, p=0.12)

 

Depression (BDI, mean diff [0-63])

Base: not reported
2mo
0.91 (95%CI-1.89 to 3.71, p=0.52)

12mo -2.19 (95%CI -4.69 to 0.32, p=0.09)

 

The programs were anticipated to be of approximately similar cost when group-based therapy was delivered in groups of 10 people.

 

Loss to follow-up:

12mo I: 33% / C: 34%

Loss to follow-up = 33% (at 12mo) especially by patients with spinal pain due to travelling time.

 

 

Pain duration difference between groups at time of inclusion

 

Table 2.2 Risk of bias table for intervention studies (randomized controlled trials; based on Cochrane risk of bias tool and suggestions by the CLARITY Group at McMaster University)

 

Research question: What is the effectiveness of interdisciplinary rehabilitation compared to monodisciplinary rehabilitation in adult patients with musculoskeletal chronic pain?

 

Study reference

 

(first author, publication year)

Was the allocation sequence adequately generated? a

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Definitely yes

Probably yes

Probably no

Definitely no

Was the allocation adequately concealed?b

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Definitely yes

Probably yes

Probably no

Definitely no

Blinding: Was knowledge of the allocated

interventions adequately prevented?c

 

Were patients blinded?

 

Were healthcare providers blinded?

 

Were data collectors blinded?

 

Were outcome assessors blinded?

 

Were data analysts blinded?

 

Definitely yes

Probably yes

Probably no

Definitely no

Was loss to follow-up (missing outcome data) infrequent?d

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Definitely yes

Probably yes

Probably no

Definitely no

Are reports of the study free of selective outcome reporting?e

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Definitely yes

Probably yes

Probably no

Definitely no

Was the study apparently free of other problems that could put it at a risk of bias?f

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Definitely yes

Probably yes

Probably no

Definitely no

Overall risk of bias

If applicable/necessary, per outcome measureg

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LOW

Some concerns

HIGH

 

Bendix (2000)

Probably yes;

 

Reason: randomization, or rather stratification by minimization, was intended to equalize age, gender, days of sick leave, pain, disability, physical measures and smoking

No information;

 

 

Probably no;

 

Reason: patients had to accept the result of randomization and knew assignment to the treatment group.

 

Blinding of assessor successful for approx. 80% of the patients.

Probably yes;

 

Reason:

Loss to follow-up:

1 year I: 17.2% / C: 31.1%

Several ITT analyses done. Baseline values of drop-outs were compared. Tendency towards worse outcomes among drop-out patients can be noted, but similar in both arms.

Also no bias found between patients who did/did not show up for follow-up assessment

Definitely yes;

 

Reason: at posttreatment, all relevant outcomes were reported

Study doesn’t include reflection on methodology

 

Little to no description of instruments for outcome measurements

Some concerns

 

Baseline imbalance on work capability

Jousset (2004)

Definitely yes;

 

Reason: Block randomization was performed using an eight element

permutation table

No information;

Probably no;

 

Reason: The

evaluation was not blind, but cooperation at all times between all evaluators and standardization tended to reduce possible

discrepancies. Blind allocation to I or C for patients not reported

Probably yes;

 

Reason: no dropout at 6 months among the patients having completed the program. Small infrequent dropout during follow-up assessment

Definitely yes;

 

Reason: All relevant outcomes were reported;

Probably no;

 

Reason: the evaluation at 6 months could not be performed based on all patients. Four patients could not come to the clinic and did not perform the physical evaluation.

Some patients refused part of the tests, either because of pain or fear of pain.

 

The evaluation was not blind, but cooperation at all times between

all evaluators and standardization tended to reduce possible

discrepancies.

 

Several baseline differences were significant (such as HAD scale)

 

Some patients with lower evaluations at inclusion did not perform the tests at 6 months, and this has possibly induced an overestimation of the results, probably more important in the

AIT group.

Some concerns

Anxiety/depression (sign baseline diff)

 

PILE-test (selective/MNAR loss to follow-up)

 

HAD-scale

(baseline diff)

 

 

Kääpä 2006

Definitely yes;

 

Reason: The

randomization list was generated by an independent biostatistician

using a table of random numbers

Definitely yes;

 

Reason: All

the envelopes were numbered consecutively to avoid rearrangement

of the order.

Physiotherapist opened an opaque sealed envelope

Probably no;

 

Reason: patient and care providers were (probably) not blinded for group allocation

Probably yes;

 

Reason: comparable (low) dropout rate in both groups. No imputation for missing questionnaire. values

 

Definitely yes;

 

Reason: All relevant outcomes were reported

Definitely yes;

 

Reason: No other problems noted

Some concerns

sick leave

(afraid to go on sick leave; besides, probably not very sensitive)

Roche (2007; 2011)

 

Definitely yes;

 

Reason:

Block randomization

was undertaken with an 8-element permutation

table established by an independent methodologist.

No information;

Probably no;

 

Reason: physiotherapist who performed outcome assessment was not blinded. No information provided about blinding of patients.

 

Definitely no;

 

Reason: more patients in AIT than FRP missing at 1-year follow-up (23% vs. 6%)

 

Lost to follow-up patients were more frequently on sick leave at baseline, higher number of sick-leave days

 

Probably yes;

 

Reason: all relevant outcomes described in the Methods section are included in the Results

Probably yes;

 

Reason: no other problems noted

 

Some concerns

Ronzi (2017)

Probably yes;

 

Reason: The randomization procedure of participants

was determined by a computer randomization feature

that automatically allocated the patient to one of the treatment strategies. This system has been described in previous studies.

 

Probably yes;

 

Reason: An independent

research assistant prepared envelopes and numbered

them sequentially according to the randomization

list. Envelopes were given to the

rehabilitation physician who opened them at the end of the clinical evaluations.

Definitely no;

 

Reason: Participants, therapists, and researchers could not be blinded for the allocated treatment after randomization.

Definitely no;

 

Reason: 4/49 patients (85) in FRP group lost to follow-up, 23/54 patients (43%) in AIP group lost to follow-up

Probably yes;

 

Reason: pain, anxiety, depression not mentioned in trial register but were included in study protocol as ‘complementary outcomes’, they were not endpoints of treatment strategies.

 

 

Probably no;

 

Reason: baseline differences disability, pain, number of sick-leave days

 

HIGH

Tavafian (2011, 2014, 2017)

Probably yes;

 

Reason: Participants were randomly assigned into the intervention or control group through random permutation blocking of every 6 participants

Probably yes;

 

Reason: The sequence of allocation was concealed to the rheumatologist who selected the eligible patients. The person who was responsible for random allocation of the eligible selected patients was blind to the clinical and demographic characteristics of the patients.

 

Probably no;

 

Reason: The physician and statistical analyst were blinded to the group assignment. The patients were instructed to say nothing about their group assignment to the physician. However, no further measures were undertaken to insure blinding of the physician.

Probably yes;

 

Reasons: At three months; infrequent loss-to-follow-up (I:5/97; C:4/100)

 

24 mo: An intention-to-treat analysis using repeated measures analysis of variance (ANOVA) was used to compare the two groups over time. Differences in baseline characteristics of those providing 24-month follow-up and those who did not were assessed to determine any selection bias. Subsequent analyses were restricted to those participants providing 24-month follow-up only. Characteristics of the sample providing this follow-up were compared by treatment allocation. The mean differences of each time point of 3-, 6-, 12- and 24-month follow-up from baseline with 95% confidence intervals (CIs) was computed. Then repeated measures ANOVA was done to examine within- and between-group changes and thus determining the pattern of response over time.

Definitely yes;

 

Reasons: outcomes according to protocol

Probably yes;

 

Reason: no other problems noted

 

 

Some concerns

Castel (2013)

Definitely yes;

 

Reason: Patients were randomly assigned in a 1:1

ratio in blocks of 32 according to a computer-generated

random number table

No information;

Probably no;

 

Reason:

The participants and therapists were not blinded.

Outcome assessors were blinded

Probably no;

 

Reason: Considerable loss to follow-up and there is a difference between the groups

 

Post-treatment (I 10% / C 7%)

3 mo (I 10%; C 20%)

6 mo (I 12%; C 24%)

12 mo (I 35%; C 53%)

Probably yes;

 

Reason: all relevant outcomes described in the Methods section are included in the Results

Probably yes;

 

Reason: no other problems noted

Some concerns

Van Eijk-Hustings (2013)

Definitely yes;

 

Reason: computer-generated random numbers

Probably yes;

 

Reason: opaque, sealed envelopes

Probably no;

 

Reasons:

There was no blinding to treatment of therapists or participants. Patients in the UC group were not informed about any intervention. Only those who were randomised to MD or AE were invited to participate in the intervention without being informed about the alternative treatment conditions

Definitely no;

 

Reasons: 67 started MD (despite 108 being randomised to MD), 60 completed MD. Only 19 started AE (despite 47 being randomised to AE), only 8 completed AE. No loss to fu in UC group.

Definitely yes;

 

Reason: all outcomes described in the Methods section are reported

Despite randomisation, the MD group turned out to be the group with the worst condition at inflow and thus had the largest potential for improvement.

 

Study conducted both ITT and PP analyses, but loss-to-follow-up may be too large.

HIGH

(HR-QoL , FIQ-total)

Martín (2011, 2014a, 2014b)

 

Definitely yes;

 

Reason: a list of random numbers was developed by the statistician

Definitely no;

 

Reason: open random allocation by a list of random numbers

Probably no;

 

Reason: data was collected by a researcher not involved in providing treatment.

Unclear whether patients were aware of group allocation

Definitely no;

 

Reason: relatively high loss to follow-up at 6mo. resp. 40% (I) and 38% (C).

Different dropout rate at assignment/during intervention/follow-up

Definitely yes;

 

Reason: All relevant outcomes were reported

1) participants were selected from patients referred to a hospital pain management unit (sample might experience greater impact of FM on HRQOL than patients treated in primary care),
2) females were over-represented in our sample.

High risk

FIQ:

Indication of regression to the mean.

Skouen (2006)

Probably yes;

 

Reason:

The allocation

sequence was prepared beforehand by a physician outside

the clinic. No stratification was

not performed. For each group of 60 patients of the

total of 664, 25 were randomly assigned to treatment as-

usual, 20 to the light program and 15 to the extensive

program. (block randomization due to limited capacity

at the clinic)

No information;

No information;

Probably yes;

 

Reason: infrequent loss to follow up (I: 5%; C 3%)

 

 

 

Probably yes;

 

Reason: relevant outcome was reported

 

 

Probably no;

 

This sample of patients with chronic widespread pain was part of a larger study among patients with different kinds of long-term musculoskeletal pain. Was this a pre-planned subgroup analysis?

Some concerns

Becker (2000)

No information;

Probably yes;

 

Reason: sealed envelopes

Definitely no;

 

Reason: patients were not blinded and statistical analyses were not performed blind to treatment condition

Probably yes;

 

Reason: Two patients in the MPT-group were excluded because of manic-depressive disorders, and five patients did not return questionnaires. In the GP-group four patients were excluded for ethical reasons and given MPT, and 12 patients did not return questionnaires. Patients who were excluded or dropped out of the study did not differ from patients included in the study with respect to demographic data, pain epidemiology or HRQL at referral.

Probably yes;

 

Reason: all outcomes described in the Methods section are reported, no trial registration or study protocol available.

 

 

 

Probably no;

 

Reason: This study included patients suffering from chronic non-malignant pain conditions, which included a number of participants with other pain than

musculoskeletal pain (e.g. abdominal pain)

Some concerns

 

Turner-Stokes (2003)

Probably yes;

 

Reason: a weighted randomization procedure was followed

 

No information;

Definitely no;

 

Reason: full blinding not possible. Both therapists and participants were aware of group allocation

Probably no;

 

Reason:

Dropout rate during treatment was 10 %. Total dropout rate at follow-up assessment was 33%.

Not-at-random dropout of spinal pain patients, but likely the same in both groups

Definitely yes;

 

Reason: All relevant outcomes were reported

Definitely yes;

 

Reason: No other problems noted

Some concerns

Pain

(baseline imbalance in pain duration (but corrected for))

 

Level of evidence of the literature

 

All evidence was derived from randomized controlled trials, therefore, the level of evidence for all outcomes started at ‘high quality’.

 

HRQoL

The level of evidence regarding the outcome measure HRQoL was downgraded by three levels because of study limitations (-1; risk of bias because of potential issues with randomisation, lack of blinding, loss to follow-up); heterogeneity (-1; inconsistency between studies); and number of included patients (-1; imprecision).

 

Disability

The level of evidence regarding the outcome measure disability was downgraded by three levels because of study limitations (-2; risk of bias because of potential issues with allocation, baseline difference, lack of blinding, loss to follow-up); heterogeneity (-1; inconsistency between studies); and number of included patients (-1; imprecision).

 

Self-efficacy

No studies reported on self-efficacy.

 

Pain

The level of evidence regarding the outcome measure pain was downgraded by three levels because of study limitations (-2; risk of bias because of potential issues with allocation, baseline differences, lack of blinding, loss to follow-up); and number of included patients (-1; imprecision).

 

Anxiety

The level of evidence regarding the outcome measure anxiety was downgraded by three levels because of study limitations (-1; risk of bias because of potential issues with allocation, lack of blinding, loss to follow-up); heterogeneity (-1; inconsistency between studies); and number of included patients (-1; imprecision).

 

Depression

The level of evidence regarding the outcome measure depression was downgraded by three levels because of study limitations (-1; risk of bias because of potential issues with allocation, lack of blinding, loss to follow-up); heterogeneity (-1; inconsistency between studies); and number of included patients (-1; imprecision).

 

Cost-effectiveness

No studies reported on cost-effectiveness.

 

Work participation

The level of evidence regarding the outcome measure work participation was downgraded by two levels because of study limitations (-1; risk of bias because of potential issues with allocation, lack of blinding, baseline differences); and number of included patients (-1; imprecision).

Definition interdisciplinary rehabilitation

The working group defined interdisciplinary rehabilitation according to the definition by Gatchel, 2014, i.e.:

(a) a common philosophy treatment in line with the biopsychosocial model of pain;
(b) a treatment component where patients actively participated by means of tasks, training and/or exercise;
(c) at least three different healthcare professionals from various disciplines that provided the interdisciplinary treatment;
(d) a single facility where each patient received treatment. This last criterion excluded care-network settings, but not multicenter trials.

 

Relevant outcome measures

The guideline development group considered health-related quality of life (HRQOL), (dis)ability and self-efficacy as a critical outcome measure for decision making; and pain, anxiety, depression, cost-effectiveness and work participation as an important outcome measure for decision making.

 

The outcome measure work participation was defined as sick leave/days, return to work and percentage employed. Return to work and employment was defined as actual return to work, not the ability to work. A priori, the working group did not define the outcome measures listed above but used the definitions of the selected studies. The outcomes had to be measured with a validated questionnaire or scale with sufficient clinimetric properties, specifically responsiveness.

 

Clinically relevant differences

The working group defined the following clinically relevant differences:

  • HRQOL, pain, disability, self-efficacy, depression, anxiety: ≥10% difference. This difference is based on baseline scores, e.g. ≥0.6 points difference between groups posttreatment, when mean baseline score is 6.0.
  • Work participation: percentage employed: ≥10%
  • Return to work: ≥ 2 weeks earlier/later
  • Sick leave/days: ≥ 2 weeks more/less in one year
  • Cost effectiveness: threshold €16,000 / €80,000 per QALY in the Netherlands

Search and select (Methods)

One literature search was performed for all abovementioned questions. The databases Medline (via OVID) and Embase (via Embase.com) were searched with relevant search terms until November 3rd, 2020. The detailed search strategy is depicted under the tab Methods. The systematic literature search resulted in 2.723 hits. Studies were selected based on the following criteria: systematic review or randomized controlled trial; study design according to one or more of the four relevant PICOs; interdisciplinary rehabilitation according to Gatchel, 2014. In case of mixed cohorts, at least 75% of the patients had to experience musculoskeletal chronic pain.

 

238 studies were initially selected based on title and abstract screening. After reading the full text, 201 publications were excluded (see the table with reasons for exclusion under the tab Methods), and 37 publications were included (Becker, 2000; Bendix, 2000; Bliokas, 2007; Brendbekken, 2016; Brendbekken, 2017; Castel, 2013; van Eijk-Hustings, 2013; Goossens, 2015; den Hollander, 2016; den Hollander, 2018; Jousset, 2004; Kääpä, 2006; Kool, 2007; Leeuw, 2008; Lera, 2009; Linden, 2014; Mangels, 2009; Martín, 2012; Martín, 2014; Martín, 2014; Monticone, 2013; Nicholas, 2013; Nicholas, 2017; Reneman, 2020; Roche, 2007; Roche-Leboucher, 2011; Ronzi, 2017; Schmidt, 2021; Skouen, 2006; Smeets, 2006; Smeets, 2008; Smeets, 2009; Tavafian, 2011; Tavafian, 2014; Tavafian, 2017; Thieme, 2003; Turner-Stokes, 2003).

 

The guideline working group was aware of three additional relevant publications that were also included (Castel, 2013; Kool, 2007; Smeets, 2009), for a total of 38 publications.

  1. Becker N, Sjøgren P, Bech P, Olsen AK, Eriksen J. Treatment outcome of chronic non-malignant pain patients managed in a danish multidisciplinary pain centre compared to general practice: a randomised controlled trial. Pain. 2000 Feb;84(2-3):203-11. doi: 10.1016/s0304-3959(99)00209-2. PMID: 10666525.
  2. Bendix T, Bendix A, Labriola M, Haestrup C, Ebbehøj N. Functional restoration versus outpatient physical training in chronic low back pain: a randomized comparative study. Spine (Phila Pa 1976). 2000 Oct 1;25(19):2494-500. doi: 10.1097/00007632-200010010-00012. PMID: 11013502.
  3. Castel A, Fontova R, Montull S, Periñán R, Poveda MJ, Miralles I, Cascón-Pereira R, Hernández P, Aragonés N, Salvat I, Castro S, Monterde S, Padrol A, Sala J, Añez C, Rull M. Efficacy of a multidisciplinary fibromyalgia treatment adapted for women with low educational levels: a randomized controlled trial. Arthritis Care Res (Hoboken). 2013 Mar;65(3):421-31. doi: 10.1002/acr.21818. PMID: 22899402.
  4. Jousset N, Fanello S, Bontoux L, Dubus V, Billabert C, Vielle B, Roquelaure Y, Penneau-Fontbonne D, Richard I. Effects of functional restoration versus 3 hours per week physical therapy: a randomized controlled study. Spine (Phila Pa 1976). 2004 Mar 1;29(5):487-93; discussion 494. doi: 10.1097/01.brs.0000102320.35490.43. PMID: 15129059.
  5. Kääpä EH, Frantsi K, Sarna S, Malmivaara A. Multidisciplinary group rehabilitation versus individual physiotherapy for chronic nonspecific low back pain: a randomized trial. Spine (Phila Pa 1976). 2006 Feb 15;31(4):371-6. doi: 10.1097/01.brs.0000200104.90759.8c. PMID: 16481945.
  6. Martín J, Torre F, Aguirre U, González N, Padierna A, Matellanes B, Quintana JM. Evaluation of the interdisciplinary PSYMEPHY treatment on patients with fibromyalgia: a randomized control trial. Pain Med. 2014 Apr;15(4):682-91. doi: 10.1111/pme.12375. Epub 2014 Feb 27. PMID: 24576148.
  7. Martín J, Torre F, Padierna A, Aguirre U, González N, García S, Matellanes B, Quintana JM. Six-and 12-month follow-up of an interdisciplinary fibromyalgia treatment programme: results of a randomised trial. Clin Exp Rheumatol. 2012 Nov-Dec;30(6 Suppl 74):103-11. Epub 2012 Dec 14. PMID: 23261008.
  8. Martín J, Torre F, Padierna A, Aguirre U, González N, Matellanes B, Quintana JM. Interdisciplinary treatment of patients with fibromyalgia: improvement of their health-related quality of life. Pain Pract. 2014 Nov;14(8):721-31. doi: 10.1111/papr.12134. Epub 2013 Nov 27. PMID: 24279638.
  9. Roche G, Ponthieux A, Parot-Shinkel E, Jousset N, Bontoux L, Dubus V, Penneau-Fontbonne D, Roquelaure Y, Legrand E, Colin D, Richard I, Fanello S. Comparison of a functional restoration program with active individual physical therapy for patients with chronic low back pain: a randomized controlled trial. Arch Phys Med Rehabil. 2007 Oct;88(10):1229-35. doi: 10.1016/j.apmr.2007.07.014. PMID: 17908562.
  10. Roche-Leboucher G, Petit-Lemanac'h A, Bontoux L, Dubus-Bausière V, Parot-Shinkel E, Fanello S, Penneau-Fontbonne D, Fouquet N, Legrand E, Roquelaure Y, Richard I. Multidisciplinary intensive functional restoration versus outpatient active physiotherapy in chronic low back pain: a randomized controlled trial. Spine (Phila Pa 1976). 2011 Dec 15;36(26):2235-42. doi: 10.1097/BRS.0b013e3182191e13. PMID: 21415807.
  11. Ronzi Y, Roche-Leboucher G, Bègue C, Dubus V, Bontoux L, Roquelaure Y, Richard I, Petit A. Efficiency of three treatment strategies on occupational and quality of life impairments for chronic low back pain patients: is the multidisciplinary approach the key feature to success? Clin Rehabil. 2017 Oct;31(10):1364-1373. doi: 10.1177/0269215517691086. Epub 2017 Feb 13. PMID: 28592147.
  12. Skouen JS, Grasdal A, Haldorsen EM. Return to work after comparing outpatient multidisciplinary treatment programs versus treatment in general practice for patients with chronic widespread pain. Eur J Pain. 2006 Feb;10(2):145-52. doi: 10.1016/j.ejpain.2005.02.005. PMID: 16310718.
  13. Tavafian SS, Jamshidi AR, Mohammad K. Treatment of chronic low back pain: a randomized clinical trial comparing multidisciplinary group-based rehabilitation program and oral drug treatment with oral drug treatment alone. Clin J Pain. 2011 Nov-Dec;27(9):811-8. doi: 10.1097/AJP.0b013e31821e7930. PMID: 21642845.
  14. Tavafian SS, Jamshidi AR, Mohammad K. Treatment of low back pain: randomized clinical trial comparing a multidisciplinary group-based rehabilitation program with oral drug treatment up to 12 months. Int J Rheum Dis. 2014 Feb;17(2):159-64. doi: 10.1111/1756-185X.12116. Epub 2013 Jun 21. PMID: 24576271.
  15. Tavafian SS, Jamshidi AR, Shay B. Treatment of low back pain: First extended follow up of an original trial (NCT00600197) comparing a multidisciplinary group-based rehabilitation program with oral drug treatment alone up to 24 months. Int J Rheum Dis. 2017 Dec;20(12):1902-1909. doi: 10.1111/1756-185X.12468. Epub 2014 Oct 10. PMID: 25307829.
  16. Turner-Stokes L, Erkeller-Yuksel F, Miles A, Pincus T, Shipley M, Pearce S. Outpatient cognitive behavioral pain management programs: a randomized comparison of a group-based multidisciplinary versus an individual therapy model. Arch Phys Med Rehabil. 2003 Jun;84(6):781-8. doi: 10.1016/s0003-9993(03)00015-7. PMID: 12808527.
  17. van Eijk-Hustings Y, Kroese M, Tan F, Boonen A, Bessems-Beks M, Landewé R. Challenges in demonstrating the effectiveness of multidisciplinary treatment on quality of life, participation and health care utilisation in patients with fibromyalgia: a randomised controlled trial. Clin Rheumatol. 2013 Feb;32(2):199-209. doi: 10.1007/s10067-012-2100-7. Epub 2012 Oct 10. PMID: 23053692.

Autorisatiedatum en geldigheid

Laatst beoordeeld  : 10-04-2024

Laatst geautoriseerd  : 10-04-2024

Geplande herbeoordeling  : 10-04-2028

Initiatief en autorisatie

Initiatief:
  • Nederlandse Vereniging van Revalidatieartsen
Geautoriseerd door:
  • Koninklijk Nederlands Genootschap voor Fysiotherapie
  • Nederlands Huisartsen Genootschap
  • Nederlandse Orthopaedische Vereniging
  • Nederlandse Vereniging van Revalidatieartsen
  • Nederlandse Vereniging voor Anesthesiologie
  • Nederlandse Vereniging voor Reumatologie
  • Ergotherapie Nederland
  • Nederlands Instituut van Psychologen
  • Vereniging van Oefentherapeuten Cesar en Mensendieck
  • Samenwerkingsverband Pijnpatiënten naar één stem

Algemene gegevens

De ontwikkeling/herziening van deze richtlijnmodule werd ondersteund door het Kennisinstituut van de Federatie Medisch Specialisten (www.demedischspecialist.nl/kennisinstituut) en werd gefinancierd uit de Kwaliteitsgelden Medisch Specialisten (SKMS). De financier heeft geen enkele invloed gehad op de inhoud van de richtlijnmodule.

Samenstelling werkgroep

Voor het ontwikkelen van de richtlijnmodule is in 2020 een multidisciplinaire werkgroep ingesteld, bestaande uit vertegenwoordigers van alle relevante specialismen (zie hiervoor de Samenstelling van de werkgroep) die betrokken zijn bij de zorg voor patiënten in de chronische pijnrevalidatie.

 

Werkgroep

  • prof. Dr. R.J.E.M. Smeets, hoogleraar revalidatiegeneeskunde & revalidatiearts, Universiteit Maastricht & CIR Clinics in Revalidatie Eindhoven, Nederlandse Vereniging van Revalidatieartsen (voorzitter)
  • prof. Dr. A.M.C.F. Verbunt, hoogleraar revalidatiegeneeskunde & revalidatiearts, Universiteit Maastricht & Adelante Zorggroep, Nederlandse Vereniging van Revalidatieartsen
  • drs. M.B.M. van Melick, ergotherapeut, Universiteit Maastricht, Ergotherapie Nederland
  • drs. C.J. van Oort, anesthesioloog, Ikazia Ziekenhuis, Nederlandse Vereniging voor Anesthesiologie
  • drs. S. van der Plas, huisarts, Huisartsenpraktijk Buis en Van der Plas, Nederlands Huisartsen Genootschap
  • dr. A.J.A. Köke, fysiotherapeut & bewegingswetenschapper, Universiteit Maastricht & Adelante Zorggroep, Koninklijk Nederlands Genootschap voor Fysiotherapie
  • dr. R.N.J.T.L. de Nijs, reumatoloog, Elkerliek ziekenhuis, Nederlandse Vereniging voor Reumatologie
  • drs. I.L. Thomassen-Hilgersom, patiëntvertegenwoordiger, Pijnpatiëntennaaréénstem
  • E. de Jong, oefentherapeut, Oefentherapie & Coachpraktijk Eveline de Jong, Vereniging van Oefentherapeuten Cesar en Mensendieck
  • drs. M.W. Havinga, orthopedisch chirurg, OCON Orthopedische kliniek, Nederlandse Orthopaedische Vereniging
  • dr. H.R. Schiphorst Preuper, revalidatiearts, UMCG, Nederlandse Vereniging van Revalidatieartsen
  • dr. C. D. Schröder, GZ-psycholoog, Healthsupport4you, Nederlands Instituut van Psychologen (sinds november 2022)
  • dr. J.J.A. Samwel, klinisch psycholoog, Revalis, Nederlands Instituut van Psychologen. (tot juli 2022)

Met ondersteuning van

  • dr. J. Buddeke, senior adviseur, Kennisinstituut van de Federatie Medisch Specialisten
  • drs. T. Lamberts, senior adviseur, Kennisinstituut van de Federatie Medisch Specialisten
  • dr. L. Oostendorp, adviseur, Kennisinstituut van de Federatie Medisch Specialisten
  • drs. L. Niesink-Boerboom, literatuurspecialist, Kennisinstituut van de Federatie Medisch Specialisten

Belangenverklaringen

De Code ter voorkoming van oneigenlijke beïnvloeding door belangenverstrengeling is gevolgd. Alle werkgroepleden hebben schriftelijk verklaard of zij in de laatste drie jaar directe financiële belangen (betrekking bij een commercieel bedrijf, persoonlijke financiële belangen, onderzoeksfinanciering) of indirecte belangen (persoonlijke relaties, reputatiemanagement) hebben gehad. Gedurende de ontwikkeling of herziening van een module worden wijzigingen in belangen aan de voorzitter doorgegeven. De belangenverklaring wordt opnieuw bevestigd tijdens de commentaarfase.

Een overzicht van de belangen van werkgroepleden en het oordeel over het omgaan met eventuele belangen vindt u in onderstaande tabel. De ondertekende belangenverklaringen zijn op te vragen bij het secretariaat van het Kennisinstituut van de Federatie Medisch Specialisten.

 

Werkgroeplid

Functie

Nevenfuncties

Gemelde belangen

Ondernomen actie

Smeets

Revalidatiearts

Hoogleraar Revalidatiegeneeskunde,
Lid van Wetenschappelijke Advies Raad patiëntenvereniging de Wervelkolom. Lid van Wetenschappelijk Advies Raad patiëntenvereniging HME/MO

Lid examencommissie EFIC curriculum medici

Ediotrial board lid European Journal of Physiotherapy and Pain Practice

Geen

Geen restrictie

Van Melick

Ergotherapeut

Lid van de Landelijke werkgroep Ergotherapie en chronische pijn,

Geen

Geen restrictie

Samwel

Klinisch psycholoog

Voorzitter sectie Pijnonderwijs van PA!N

Lid van het Algemeen Bestuur van PA!N als gemandateerde vanuit NIP (Nederlands Instituut voor Psychologen)

Afgevaardigde Revalis in Netwerk Chronische Pijn Jeroen Bosch Ziekenhuis

Afgevaardigde Revalis in Netwerk Chronische Pijn Bernhoven Ziekenhuis

Geen

Geen restrictie

Schiphorst-Preuper

Revalidatiearts

Revalidatiearts, Universitair docent, Lid werkgroep Pijnrevalidatie Nederland, Lid algemeen bestuur Pijn Alliantie Nederland tot 2024. Kernredactielid NTPP tot 2024. Vice voorzitter werkgroep Leidraad organisatie van zorg chronische pijn namens de VRA. Lid WPN.

Geen

Geen restricties

Schröder

GZ-psycholoog

Voorzitter sectie revalidatiepsychologie NIP

Geen

Geen restricties

Thomassen

Voorzitter Samenwerkingsverband Pijnpatiënten naar één stem

Voorzitter Patiëntenvereniging CRPS

Geen

Geen restricties

Verbunt

Revalidatiearts

Hoogleraar revalidatie-geneeskunde. Commissie VENI ZonMW betaald,

Vice voorzitter wetenschaps-commissie VRA

Editioral board lid European Journal of Pain

Project Netwerk Pijnrevalidatie Limburg, gefinancierd door zorgverzekeraars VGZ, CZ en Zilveren Kruis

Geen restricties

De Jong

Oefentherapeut

Bestuurslid Landelijk Netwerk Oefentherapeuten Chronische Pijn

Geen

Geen restricties

De Nijs

Reumatoloog

geen

Adviesraad AMGEN met betrekking tot osteoporose. PROFILE trial Sarilumab bij RA (gefinancierd door Sanofi Genzyme)

Aandelen in Farma & medische technologie

Restrictie: Is niet betrokken bij de besluitvorming rondom wel/niet afbouwen van pijnmedicatie voor start MSR.

Havinga

Orthopedisch chirurg

Lid beroepsbelangen-commissie NOV

Geen

Geen restrictie

Köke

Senior onderzoeker Revalidatie-geneeskunde

Afstudeerbegeleider Zuyd Hogeschool Heerlen, opleiding fysiotherapie.

Coördinator Innovatie Kenniscentrum Adelante Hoensbroek

Geen

Geen restricties

Van Oort

Anesthesioloog

Anesthesioloog-pijnspecialist (tot 2022)

Lid Centraal Medisch Tuchtcollege;

adviseur NVA;

Geen

Geen resricties

Van der Plas

Huisarts, praktijkhouder, kaderhuisarts bewegingsapparaat

Instructeur Outdoor Medicine: vrijwilligersvergoeding

 

Medische commissie Nederlandse Klim- en bergsport Vereniging: vrijwillig en onbetaald

 

Nascholingen geven bij huisartsen coöperatie Medicamus: betaald

 

Lezingen en workshops geven over outdoor- en bergsportgeneeskunde op persoonlijke titel: vrijwillig met onkostenvergoeding

 

Geen restricties

Inbreng patiëntenperspectief

Er werd aandacht besteed aan het patiëntenperspectief door de patiëntorganisaties Pijnpatiëntennaaréénstem en de Patiëntenfederatie Nederland uit te nodigen voor de invitational conference. Het verslag hiervan [zie bijlagen] is besproken in de werkgroep. Ook heeft een afgevaardigde van de patiëntenvereniging Pijnpatiëntennaaréénstem zitting genomen in de werkgroep.

De conceptrichtlijn is tevens voor commentaar voorgelegd aan de Patiëntenfederatie Nederland en Pijnpatiëntennaaréénstem en de eventueel aangeleverde commentaren zijn bekeken en verwerkt.

 

Wkkgz & Kwalitatieve raming van mogelijke substantiële financiële gevolgen

Kwalitatieve raming van mogelijke financiële gevolgen in het kader van de Wkkgz

Bij de richtlijn is conform de Wet kwaliteit, klachten en geschillen zorg (Wkkgz) een kwalitatieve raming uitgevoerd of de aanbevelingen mogelijk leiden tot substantiële financiële gevolgen. Bij het uitvoeren van deze beoordeling zijn richtlijnmodules op verschillende domeinen getoetst (zie het stroomschema op de Richtlijnendatabase).

 

Uit de kwalitatieve raming blijkt dat er waarschijnlijk geen substantiële financiële gevolgen zijn, zie onderstaande tabel.

 

Module

Uitkomst raming

Toelichting

Module Effectiviteit Interdisciplinaire revalidatie

Geen financiële gevolgen

Uitkomst 3. Op basis van gegevens uit het DBC-informatiesysteem (DIS) wordt aangenomen dat er jaarlijks minder dan 15.000-20.000 WPN 3 en 4 patiënten zijn. Verder worden geen substantiële investeringen bij het uitvoeren van de aanbevelingen verwacht.

Werkwijze

AGREE

Deze richtlijnmodule is opgesteld conform de eisen vermeld in het rapport Medisch Specialistische Richtlijnen 2.0 van de adviescommissie Richtlijnen van de Raad Kwaliteit. Dit rapport is gebaseerd op het AGREE II instrument (Appraisal of Guidelines for Research & Evaluation II; Brouwers, 2010).

 

Knelpuntenanalyse en uitgangsvragen

Tijdens de voorbereidende fase inventariseerde de werkgroep de knelpunten in de chronische pijnrevalidatie. Tevens zijn er knelpunten aangedragen door verschillende partijen via een schriftelijke knelpunteninventarisatie en een invitational conference. Een verslag van de invitational conference is opgenomen als bijlage.

 

Op basis van de uitkomsten van de knelpuntenanalyse zijn door de werkgroep concept-uitgangsvragen opgesteld en definitief vastgesteld.

 

Uitkomstmaten

Na het opstellen van de zoekvraag behorende bij de uitgangsvraag inventariseerde de werkgroep welke uitkomstmaten voor de patiënt relevant zijn, waarbij zowel naar gewenste als ongewenste effecten werd gekeken. Hierbij werd een maximum van acht uitkomstmaten gehanteerd. De werkgroep waardeerde deze uitkomstmaten volgens hun relatieve belang bij de besluitvorming rondom aanbevelingen, als cruciaal (kritiek voor de besluitvorming), belangrijk (maar niet cruciaal) en onbelangrijk. Tevens definieerde de werkgroep tenminste voor de cruciale uitkomstmaten welke verschillen zij klinisch (patiënt) relevant vonden.

 

Methode literatuursamenvatting

Een uitgebreide beschrijving van de strategie voor zoeken en selecteren van literatuur is te vinden onder ‘Zoeken en selecteren’ onder Onderbouwing. Indien mogelijk werd de data uit verschillende studies gepoold in een random-effects model. Review Manager 5.4 werd gebruikt voor de statistische analyses. De beoordeling van de kracht van het wetenschappelijke bewijs wordt hieronder toegelicht. De beoordeling van de methodologische kwaliteit van de literatuur is uitgevoerd door adviseurs van het Kennisinstituut van de Federatie Medisch Specialisten.

 

Beoordelen van de kracht van het wetenschappelijke bewijs

De kracht van het wetenschappelijke bewijs werd bepaald volgens de GRADE-methode. GRADE staat voor ‘Grading Recommendations Assessment, Development and Evaluation’ (zie http://www.gradeworkinggroup.org/). De basisprincipes van de GRADE-methodiek zijn: het benoemen en prioriteren van de klinisch (patiënt) relevante uitkomstmaten, een systematische review per uitkomstmaat, en een beoordeling van de bewijskracht per uitkomstmaat op basis van de acht GRADE-domeinen (domeinen voor downgraden: risk of bias, inconsistentie, indirectheid, imprecisie, en publicatiebias; domeinen voor upgraden: dosis-effect relatie, groot effect, en residuele plausibele confounding).

GRADE onderscheidt vier gradaties voor de kwaliteit van het wetenschappelijk bewijs: hoog, redelijk, laag en zeer laag. Deze gradaties verwijzen naar de mate van zekerheid die er bestaat over de literatuurconclusie, in het bijzonder de mate van zekerheid dat de literatuurconclusie de aanbeveling adequaat ondersteunt (Schünemann, 2013; Hultcrantz, 2017).

 

GRADE

Definitie

Hoog

  • er is hoge zekerheid dat het ware effect van behandeling dichtbij het geschatte effect van behandeling ligt;
  • het is zeer onwaarschijnlijk dat de literatuurconclusie klinisch relevant verandert wanneer er resultaten van nieuw grootschalig onderzoek aan de literatuuranalyse worden toegevoegd.

Redelijk

  • er is redelijke zekerheid dat het ware effect van behandeling dichtbij het geschatte effect van behandeling ligt;
  • het is mogelijk dat de conclusie klinisch relevant verandert wanneer er resultaten van nieuw grootschalig onderzoek aan de literatuuranalyse worden toegevoegd.

Laag

  • er is lage zekerheid dat het ware effect van behandeling dichtbij het geschatte effect van behandeling ligt;
  • er is een reële kans dat de conclusie klinisch relevant verandert wanneer er resultaten van nieuw grootschalig onderzoek aan de literatuuranalyse worden toegevoegd.

Zeer laag

  • er is zeer lage zekerheid dat het ware effect van behandeling dichtbij het geschatte effect van behandeling ligt;
  • de literatuurconclusie is zeer onzeker.

 

Bij het beoordelen (graderen) van de kracht van het wetenschappelijk bewijs in richtlijnen volgens de GRADE-methodiek spelen grenzen voor klinische besluitvorming een belangrijke rol (Hultcrantz, 2017). Dit zijn de grenzen die bij overschrijding aanleiding zouden geven tot een aanpassing van de aanbeveling. Om de grenzen voor klinische besluitvorming te bepalen moeten alle relevante uitkomstmaten en overwegingen worden meegewogen. De grenzen voor klinische besluitvorming zijn daarmee niet één op één vergelijkbaar met het minimaal klinisch relevant verschil (Minimal Clinically Important Difference, MCID). Met name in situaties waarin een interventie geen belangrijke nadelen heeft en de kosten relatief laag zijn, kan de grens voor klinische besluitvorming met betrekking tot de effectiviteit van de interventie bij een lagere waarde (dichter bij het nuleffect) liggen dan de MCID (Hultcrantz, 2017).

 

De werkgroep voorzag reeds bij de start van het ontwikkeltraject dat de bewijskracht van de beschikbare evidence, beoordeeld middels GRADE, laag tot zeer laag zou zijn. Er zijn een aantal beperkingen inherent aan onderzoek in het domein revalidatiegeneeskunde, waaronder de onmogelijkheid om volledige blindering toe te passen en de kosten van behandeling waardoor het aantal geïncludeerde patiënten laag blijft, met onzekerheid in de grootte van het effect tot gevolg. Gezien deze beperkingen ligt het niet in de lijn der verwachting dat de bewijskracht zoals beoordeeld met GRADE in de toekomst hoger uit zal vallen.

 

In de module Interdisciplinaire Pijnrevalidatie heeft de werkgroep in de overwegingen een uitgebreide reflectie geschreven hieromtrent omdat zij van mening is dat er meer bewijs voorhanden is dan aan de hand van de GRADE methodiek in de literatuuranalyse is beschreven. Aanvullend bewijs verkregen via onderzoeksdesigns zoals Single Case Experimental Designs (SCED) en cohortstudies heeft een plaats gekregen in de overwegingen. De werkgroep heeft al het wetenschappelijk bewijs gewogen in de overwegingen en tot uitdrukking proberen te brengen in haar aanbevelingen.

 

Overwegingen (van bewijs naar aanbeveling)

Om te komen tot een aanbeveling zijn naast (de kwaliteit van) het wetenschappelijke bewijs ook andere aspecten belangrijk en worden meegewogen, zoals aanvullende argumenten uit bijvoorbeeld de biomechanica of fysiologie, waarden en voorkeuren van patiënten, kosten (middelenbeslag), aanvaardbaarheid, haalbaarheid en implementatie. Deze aspecten zijn systematisch vermeld en beoordeeld (gewogen) onder het kopje ‘Overwegingen’ en kunnen (mede) gebaseerd zijn op expert opinion. Hierbij is gebruik gemaakt van een gestructureerd format gebaseerd op het evidence-to-decision framework van de internationale GRADE Working Group (Alonso-Coello, 2016a; Alonso-Coello 2016b). Dit evidence-to-decision framework is een integraal onderdeel van de GRADE methodiek.

 

Formuleren van aanbevelingen

De aanbevelingen geven antwoord op de uitgangsvraag en zijn gebaseerd op het beschikbare wetenschappelijke bewijs en de belangrijkste overwegingen, en een weging van de gunstige en ongunstige effecten van de relevante interventies. De kracht van het wetenschappelijk bewijs en het gewicht dat door de werkgroep wordt toegekend aan de overwegingen, bepalen samen de sterkte van de aanbeveling. Conform de GRADE-methodiek sluit een lage bewijskracht van conclusies in de systematische literatuuranalyse een sterke aanbeveling niet a priori uit, en zijn bij een hoge bewijskracht ook zwakke aanbevelingen mogelijk (Agoritsas, 2017; Neumann, 2016). De sterkte van de aanbeveling wordt altijd bepaald door weging van alle relevante argumenten tezamen. De werkgroep heeft bij elke aanbeveling opgenomen hoe zij tot de richting en sterkte van de aanbeveling zijn gekomen.

In de GRADE-methodiek wordt onderscheid gemaakt tussen sterke en zwakke (of conditionele) aanbevelingen. De sterkte van een aanbeveling verwijst naar de mate van zekerheid dat de voordelen van de interventie opwegen tegen de nadelen (of vice versa), gezien over het hele spectrum van patiënten waarvoor de aanbeveling is bedoeld. De sterkte van een aanbeveling heeft duidelijke implicaties voor patiënten, behandelaars en beleidsmakers (zie onderstaande tabel). Een aanbeveling is geen dictaat, zelfs een sterke aanbeveling gebaseerd op bewijs van hoge kwaliteit (GRADE gradering HOOG) zal niet altijd van toepassing zijn, onder alle mogelijke omstandigheden en voor elke individuele patiënt.

 

Implicaties van sterke en zwakke aanbevelingen voor verschillende richtlijngebruikers

 

Sterke aanbeveling

Zwakke (conditionele) aanbeveling

Voor patiënten

De meeste patiënten zouden de aanbevolen interventie of aanpak kiezen en slechts een klein aantal niet.

Een aanzienlijk deel van de patiënten zouden de aanbevolen interventie of aanpak kiezen, maar veel patiënten ook niet.

Voor behandelaars

De meeste patiënten zouden de aanbevolen interventie of aanpak moeten ontvangen.

Er zijn meerdere geschikte interventies of aanpakken. De patiënt moet worden ondersteund bij de keuze voor de interventie of aanpak die het beste aansluit bij zijn of haar waarden en voorkeuren.

Voor beleidsmakers

De aanbevolen interventie of aanpak kan worden gezien als standaardbeleid.

Beleidsbepaling vereist uitvoerige discussie met betrokkenheid van veel stakeholders. Er is een grotere kans op lokale beleidsverschillen.

 

Organisatie van zorg

In de knelpuntenanalyse en bij de ontwikkeling van de richtlijnmodule is expliciet aandacht geweest voor de organisatie van zorg: alle aspecten die randvoorwaardelijk zijn voor het verlenen van zorg (zoals coördinatie, communicatie, (financiële) middelen, mankracht en infrastructuur). Randvoorwaarden die relevant zijn voor het beantwoorden van deze specifieke uitgangsvraag zijn genoemd bij de overwegingen. Meer algemene, overkoepelende, of bijkomende aspecten van de organisatie van zorg worden behandeld in de module Organisatie van zorg.

 

Commentaar- en autorisatiefase

De conceptrichtlijnmodule werd aan de betrokken (wetenschappelijke) verenigingen en (patiënt) organisaties voorgelegd ter commentaar. De commentaren werden verzameld en besproken met de werkgroep. Naar aanleiding van de commentaren werd de conceptrichtlijnmodule aangepast en definitief vastgesteld door de werkgroep. De definitieve richtlijnmodule werd aan de deelnemende (wetenschappelijke) verenigingen en (patiënt) organisaties voorgelegd voor autorisatie en door hen geautoriseerd dan wel geaccordeerd.

 

Literatuur

Agoritsas T, Merglen A, Heen AF, Kristiansen A, Neumann I, Brito JP, Brignardello-Petersen R, Alexander PE, Rind DM, Vandvik PO, Guyatt GH. UpToDate adherence to GRADE criteria for strong recommendations: an analytical survey. BMJ Open. 2017 Nov 16;7(11):e018593. doi: 10.1136/bmjopen-2017-018593. PubMed PMID: 29150475; PubMed Central PMCID: PMC5701989.

 

Alonso-Coello P, Schünemann HJ, Moberg J, Brignardello-Petersen R, Akl EA, Davoli M, Treweek S, Mustafa RA, Rada G, Rosenbaum S, Morelli A, Guyatt GH, Oxman AD; GRADE Working Group. GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction. BMJ. 2016 Jun 28;353:i2016. doi: 10.1136/bmj.i2016. PubMed PMID: 27353417.

 

Alonso-Coello P, Oxman AD, Moberg J, Brignardello-Petersen R, Akl EA, Davoli M, Treweek S, Mustafa RA, Vandvik PO, Meerpohl J, Guyatt GH, Schünemann HJ; GRADE Working Group. GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines. BMJ. 2016 Jun 30;353:i2089. doi: 10.1136/bmj.i2089. PubMed PMID: 27365494.

 

Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers B, Graham ID, Grimshaw J, Hanna SE, Littlejohns P, Makarski J, Zitzelsberger L; AGREE Next Steps Consortium. AGREE II: advancing guideline development, reporting and evaluation in health care. CMAJ. 2010 Dec 14;182(18):E839-42. doi: 10.1503/cmaj.090449. Epub 2010 Jul 5. Review. PubMed PMID: 20603348; PubMed Central PMCID: PMC3001530.

 

Hultcrantz M, Rind D, Akl EA, Treweek S, Mustafa RA, Iorio A, Alper BS, Meerpohl JJ, Murad MH, Ansari MT, Katikireddi SV, Östlund P, Tranæus S, Christensen R, Gartlehner G, Brozek J, Izcovich A, Schünemann H, Guyatt G. The GRADE Working Group clarifies the construct of certainty of evidence. J Clin Epidemiol. 2017 Jul;87:4-13. doi: 10.1016/j.jclinepi.2017.05.006. Epub 2017 May 18. PubMed PMID: 28529184; PubMed Central PMCID: PMC6542664.

 

Medisch Specialistische Richtlijnen 2.0 (2012). Adviescommissie Richtlijnen van de Raad Kwalitieit. http://richtlijnendatabase.nl/over_deze_site/over_richtlijnontwikkeling.html

 

Neumann I, Santesso N, Akl EA, Rind DM, Vandvik PO, Alonso-Coello P, Agoritsas T, Mustafa RA, Alexander PE, Schünemann H, Guyatt GH. A guide for health professionals to interpret and use recommendations in guidelines developed with the GRADE approach. J Clin Epidemiol. 2016 Apr;72:45-55. doi: 10.1016/j.jclinepi.2015.11.017. Epub 2016 Jan 6. Review. PubMed PMID: 26772609.

 

Schünemann H, Brożek J, Guyatt G, et al. GRADE handbook for grading quality of evidence and strength of recommendations. Updated October 2013. The GRADE Working Group, 2013. Available from http://gdt.guidelinedevelopment.org/central_prod/_design/client/handbook/handbook.html.

Volgende:
Nazorg